2021 m. Publikacijos, pranešimai

1. Mathelin C, Ame S, Anyanwu S, Avisar E, Boubnider WM, Breitling K, Anie HA, Conceição JC, Dupont V, Elder E, Elfgen C, Elonge T, Iglesias E, Imoto S, Ioannidou-Mouzaka L, Kappos EA, Kaufmann M, Knauer M, Luzuy F, Margaritoni M, Mbodj M, Mundinger A, Orda R, Ostapenko V, Özbaş S, Özmen V, Pagani O, Pieńkowski T, Schneebaum S, Shmalts E, Selim A, Pavel Z, Lodi M, Maghales-Costa M.
   Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey.
   Eur J Breast Health. 2021 Mar 31;17(2):188–196. doi: 10.4274/ejbh.galenos.2021.2021-1-4. PMID: 33870120.
2. Kubiliute R, Januskeviciene I, Urbanaviciute R, Daniunaite K, Drobniene M, Ostapenko V, Daugelavicius R, Jarmalaite S.
   Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.
   Sci Rep. 2021 Mar 22;11(1):6556. doi: 10.1038/s41598-021-86120-6. PMID: 33753859.
3. Radziuviene G, Rasmusson A, Augulis R, Grineviciute RB, Zilenaite D, Laurinaviciene A, Ostapenko V, Laurinavicius A.
   Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients.
   Front Oncol. 2021 Nov 11;11:774088. doi: 10.3389/fonc.2021.774088. PMID: 34858854.
4. Dabkeviciene D, Vincerzevskiene I, Urbonas V, Venius J, Dulskas A, Brasiuniene B, Janulionis E, Burneckis A, Zileviciene A, Tiskevicius S, Vanseviciute-Petkeviciene R, Usinskiene J, Briediene R, Bulotiene G, Stratilatovas E, Ostapenko V, Gibaviciene J, Karnas I, Kekstaite S, Navickiene J, Ulys A, Zalimas A, Sruogis A, Kardelis Z, Zaremba S, Askinis R, Cicenas S, Tikuisis R, Ciurliene R, Jarmalaite S.
   The Impact of the COVID-19 Pandemic on Cancer Patient's Management – Lithuanian Cancer Center Experience.
   Healthcare (Basel). 2021. doi: 10.3390/healthcare9111522. PMID: 34828568.
5. Weber WP, Matrai Z, Hayoz S, Tausch C, Henke G, Zwahlen DR, Ostapenko V, Fitzal F, Nussbaumer R, Maggi N, Schulz A, Markellou P, Lelièvre L, Egle D, Heil J, Knauer M.
   Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
   Breast. 2021 Dec;60:98–110. doi: 10.1016/j.breast.2021.09.004. PMID: 34555676.